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Background—Only a few studies have focused the attention on the relation between elevated anti–Chlamydia pneumoniae
(CP) antibodies and the detection of CP in the arterial wall. The aim of our study is thus to investigate the relationship
between immune response to CP and detection of CP in the aortic walls of patients with abdominal aortic aneurysm.
Methods and Results—A specimen of aortic wall was obtained from 102 consecutive patients who underwent abdominal
aneurysm repair. The possible presence of CP was studied by polymerase chain reaction and confirmed by
nonradioactive DNA hybridization. Antibody response to CP was studied (IgG, IgA titers). We found 33 patients
(32.4%) with CP DNA1. No correlation between CP DNA detection and antibody titers was found (IgG P50.52, IgA
P50.66). High correlation between IgG and IgA titer was observed (P,0.01). Endovascular presence of CP and
antibody titers was not related to the age of the patient.
Conclusions—CP antibody titers are not associated with the presence of CP in the aortic wall of patients with abdominal
aortic aneurysm. (Circulation. 2002;106:2647-2648.)
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Seroepidemiological studies have shown an associationbetween ischemic heart disease and Chlamydia pneu-
moniae (CP) infection. Moreover, increasing evidence exists
that CP might play a role in atherosclerosis, as well. Most of
the studies concerning the relationship between CP infection
and atherosclerosis are based on serology, but the correlation
between endovascular infection with CP and antibody titers is
still unclear.1,2,3
The aim of our study was thus to investigate the relation-
ship between immune response to CP and detection of CP in
the aortic wall of patients with abdominal aortic aneurysm.
Methods
Between June 1999 and June 2000, 102 consecutive patients under-
went abdominal aortic aneurysm repair at our hospital. A specimen
from the aortic aneurysm was obtained from each patient, and the
possible presence of CP was studied by polymerase chain reaction
(PCR). Sera were tested for CP-specific antibodies.
PCR
Aortic tissue was cut into 0.2-cm segments. Genomic CP DNA was
detected by a nested PCR protocol (AMS, Clonit). For confirmation,
nonradioactive DNA hybridization was performed with oligonucle-
otide HM-1 to 39 labeled with digoxigenin-ddUTP (Boehringer).
Serology
A separate determination of IgG, IgA with the indirect immunofluo-
rescent method, was performed. An anti-CP titer $16 was consid-
ered significant for previous CP infection (BIOS TestKit 42060).
Variables are reported as mean and relative frequencies or
mean6SD. For comparison between groups, Student’s t test or
Fisher’s exact test were used as appropriate.
Results
CP DNA was detected in abdominal aortic wall of 33 of 102
patients (32.4%). There was no evidence of a difference
between patients with CP DNA1 and CP DNA2 with regard
to conventional risk factors for atherosclerosis (age, sex,
smoking history, hypertension, hypercholesterolemia,
diabetes).
IgG titer $1/16 was present in 60 of 102 patients (61%).
IgA titer $1/16 was present in 41 patients. No relationship
between serology to CP and presence of CP in the abdominal
aortic wall was observed (Table). A high correlation between
IgG and IgA serology was found (P,0.01). Endovascular
presence of CP and antibody rates were not related to the age
of the patients (P50.30, P50.40).
Discussion
To our knowledge, this is one of the largest series of patients
who underwent abdominal aneurysm repair to be investigated
for CP detection in the aortic wall. Interestingly, our study did
not identify an association between CP presence in the aortic
wall and antibody response to CP. Previous studies reported
different prevalence of CP by PCR in specimens obtained
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from abdominal aortic aneurysm, ranging from 20% to
49%.4,5,6,7 Therefore our positivity rates are within the ex-
pected range. In our study, an optimized DNA extraction
protocol to reduce any underestimation of CP prevalence was
used, and our data were confirmed by nonradioactive DNA
hybridization to enhance specificity.
Only a few studies have focused the attention on the
relation between elevated anti-CP antibodies and the detec-
tion of CP in the arterial wall. Bartels8 and Campbell9
reported that CP antibody titer is not associated with the
endovascular presence of CP in patients with coronary artery
disease. In contrast to these observations, Blasi et al10
reported a significant relationship between anti-CP antibodies
and CP detection in aortic wall specimens obtained from
abdominal aortic aneurysm.
In the past, the relationship between CP infection and
atherosclerotic disease was based on seropositivity.11 How-
ever, Ericson et al12 reported that the degree of immune
response is not a predictor of the degree of infection or the
extent of coronary atherosclerosis, but rather intracellular
infection with CP may relate to the severity of the disease.
These observations are consistent with our data that show that
the immune response to CP is not a predictor of CP infection
of the abdominal aorta.
If data reporting a lack of association between endovascu-
lar presence of CP and antibody response will be confirmed,
the value of the seroepidemiological approach to investigat-
ing CP induced atherosclerosis should be reevaluated.
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Crosstabulation Between Serum Immunoreactivity to CP (IgG,
IgA) and Detection of CP DNA in Abdominal Aortic Aneurysm
N5102
Patients
CP DNA1
[n533 (32.4)]
CP DNA2
[n569 (67.6)] P
Patients with IgG $1/16 60 (61) 21 (64) 39 (59) 0.52
Patients with IgA $1/16 41 (40) 12 (35) 29 (44) 0.66
Values are n (%).
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